Eloxx Pharmaceuticals, Inc.
ELOX
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -20.48M | -24.40M | -30.68M | -36.07M | -41.84M |
| Total Depreciation and Amortization | 737.00K | 738.00K | 683.00K | 695.00K | 719.00K |
| Total Amortization of Deferred Charges | 361.00K | 450.00K | 537.00K | 541.00K | 519.00K |
| Total Other Non-Cash Items | 2.39M | 2.90M | 2.93M | 3.10M | 4.10M |
| Change in Net Operating Assets | -997.00K | -1.18M | -2.64M | -118.00K | 387.00K |
| Cash from Operations | -17.99M | -21.49M | -29.17M | -31.85M | -36.12M |
| Capital Expenditure | 0.00 | -48.00K | -55.00K | -66.00K | -86.00K |
| Sale of Property, Plant, and Equipment | 258.00K | 25.00K | 11.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 258.00K | -23.00K | -44.00K | -66.00K | -86.00K |
| Total Debt Issued | -- | -- | -- | -- | -36.00K |
| Total Debt Repaid | -7.72M | -7.50M | -7.50M | -- | 0.00 |
| Issuance of Common Stock | 4.89M | 1.43M | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -124.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 743.00K | 1.81M | 1.81M | 8.81M | 8.50M |
| Cash from Financing | -2.09M | -4.26M | -5.69M | 8.81M | 8.34M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.82M | -25.77M | -34.90M | -23.10M | -27.86M |